Empyrean Therapeutics Ltd
- Company number
- 11372447
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 21 May 2018
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Cambridge Prime Ltd (2 companies)
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Thomas William Henley | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
21 May 2018 | 22 Jul 2019 |
| Cambridge Prime Ltd | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
7 Jul 2020 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 30 Nov 2025 | £1,590,819 | £328,689 | 5 |
| 30 Nov 2024 | £620,964 | £303,593 | 6 |
| 30 Nov 2023 | £540,097 | £2,628,436 | 7 |
| 30 Nov 2022 | £1,037,533 | £484,079 | 11 |
| 30 Nov 2021 | £867,357 | £422,493 | 10 |
| 30 Nov 2020 | £747,005 | £221,352 | 7 |
| 31 May 2019 | - | £161,181 | - |
Connections
Owned by
Empyrean Therapeutics Ltd → Cambridge Prime Ltd